Laboratory parameters and appetite regulators in patients with Anorexia nervosa

Journal of Psychiatric Practice

Volumn 16, Issue 2, 2010, Pages 82-92

  Himmerich, Hubertus ^a   Schönknecht, Peter ^a   Heitmann, Sabine ^a   Sheldrick, Abigail J ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Anorexia nervosa; Cytokines; Electrolytes; Hormones; Liver enzymes

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; CHLORIDE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ELECTROLYTE; ESTROGEN; FOLLITROPIN; GAMMA GLUTAMYLTRANSFERASE; GHRELIN; HEMOGLOBIN; HYDROCORTISONE; LEPTIN; LIOTHYRONINE; LIVER ENZYME; LUTEINIZING HORMONE; NEUROPEPTIDE Y; PANCREAS POLYPEPTIDE; POTASSIUM; SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ACROCYANOSIS; ANOREXIA NERVOSA; BODY MASS; BODY WEIGHT; BONE DENSITOMETRY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; DRY SKIN; EDEMA; FOOD INTAKE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPOTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; LABORATORY PARAMETERS; LEUKOCYTE COUNT; MEDICAL HISTORY; PARAMETER; PETECHIA; PHYSICAL EXAMINATION; PREVALENCE; REVIEW; SKIN DISEASE; TOOTH DISEASE; URINALYSIS;

ANOREXIA NERVOSA; APPETITE REGULATION; BLOOD CHEMICAL ANALYSIS; BODY IMAGE; BODY MASS INDEX; DIAGNOSIS, DIFFERENTIAL; ELECTROLYTES; HORMONES; HUMANS; MEDICAL HISTORY TAKING;

EID: 77952113742     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000369969.87779.1c     Document Type: Review

References (85)

1. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 2006;19:389-94.
2. Herzog DB, Copeland PM. Eating disorders. N Engl J Med 1985;313:295-303.
3. Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 2002;159:1284-93.
4. Sullivan PF. Mortality in anorexia nervosa. Am J Psychiatry 1995;152:1073-4.
5. Devuyst O, Lambert M, Rodhain J, et al. Haematological changes and infectious complications in anorexia nervosa: A case-control study. Q J Med 1993;86:791-9.
6. Halfter SM, Nisch C, Karges W, et al. Diagnosis and therapy of anorexia nervosa-An interdisciplinary challenge. MMW Fortschr Med 2009;151:23-6.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
8. Fairburn CG, Harrison PJ. Eating disorders: Review. Lancet 2003;361:407-16.
9. Williams PM, Goodie J, Motsinger CD. Treating eating disorders in primary care. Am Fam Physician 2008;77:187-95.
10. Mitchell JE, Crow S. Medical complications of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry 2006;19:438-43.
11. World Health Organization (WHO). International statistical classification of diseases and related health problems (ICD-10) diagnostic criteria for research. Geneva, Switzerland: WHO; 1992.
12. Fujita M, Tamai H, Mizuno O, et al. Secretory function of the renin-aldosterone system in patients with anorexia nervosa. Nippon Naibunpi Gakkai Zasshi 1991;67:50-5.
13. Backmund M. Eating disorders-How to recognize and treat them. MMW Fortschr Med 2004;17:31-3.
14. Verhoef PA, Rampal A. Unique challenges for appropriate management of a 16-year-old girl with superior mesenteric artery syndrome as a result of anorexia nervosa: A case report. J Med Case Reports 2009;3:127.
15. Misra M. Long-term skeletal effects of eating disorders with onset in adolescence. Ann N Y Acad Sci 2008;1135:212-8.
16. Katzman DK, Lambe EK, Mikulis DJ, et al. Cerebral gray matter and white matter volume deficits in adolescent girls with anorexia nervosa. J Pediatr 1996;129:794-803.
17. Lambe EK, Katzman DK, Mikulis DJ, et al. Cerebral gray matter volume deficits after weight recovery from anorexia nervosa. Arch Gen Psychiatry 1997;54:537-42.
18. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition 2001;17:632-7.
19. Huang YL, Fang CT, Tseng MC, et al. Life-threatening refeeding syndrome in a severely malnourished anorexia nervosa patient. J Formos Med Assoc 2001;100:343-6.
20. Caregaro L, Di Pascoli L, Favaro A, et al. Sodium depletion and hemoconcentration: Overlooked complications in patients with anorexia nervosa? Nutrition 2005;21:438-45.
21. Laczi F. Etiology, diagnostics and therapy of hyponatremias. Orv Hetil 2008;149:1347-54.
22. Krapf R. It is more difficult to smash a prejudice than an atom. Ther Umsch 2008;65:703-6.
23. Rajs J, Rajs E, Lundman T. Unexpected death in patients suffering from eating disorders. Acta Psychiatr Scand 1986;74:587-96.
24. Koh E, Onishi T, Morimoto S, et al. Clinical evaluation of hypokalemia in anorexia nervosa. Jpn J Med 1989;28:692-6.
25. van Rijn CA. Anorexia nervosa and bulimia nervosa. Somatic complications of purging. Ned Tijdschr Geneeskd 1998;142:1867-9.
26. Khanna A, Kurtzman NA. Metabolic alkalosis. Respir Care 2001;46:354-65.
27. Ben Salem C, Hmouda H, Bouraoui K. Drug-induced hypokalaemia. Curr Drug Saf 2009;4:55-61.
28. Bartter FC, Pronove P, Gill JR, et al. Hyperplasia of the juxtaglomerular complexes with hyperaldosteronism and hypokalemic alkalosis. Am J Med 1962;33:811-28.
29. Wada K, Shinoda T. A case report of an anorexia nervosa patient with end-stage renal disease due to pseudo Bartter's syndrome and Chinese herb nephropathy requiring maintenance hemodialysis. Ther Apher Dial 2008;12:417-20.
30. Fong HF, Divasta AD, Difabio D, et al. Prevalence and predictors of abnormal liver enzymes in young women with anorexia nervosa. J Pediatr 2008;153:247-53.
31. Tsukamoto M, Tanaka A, Arai M, et al. Hepatocellular injuries observed in patients with an eating disorder prior to nutritional treatment. Intern Med 2008;47:1447-50.
32. Miller K, Grinspoon S, Ciampa J, et al. Medical findings in outpatients with anorexia nervosa. Arch Intern Med 2005;165:561-6.
33. Furuta S, Ozawa Y, Maejima K, et al. Anorexia nervosa with severe liver dysfunction and subsequent critical complications. Intern Med 1999;38:575-9.
34. Di Pascoli L, Lion A, Milazzo D, et al. Acute liver damage in anorexia nervosa. Int J Eat Disord 2004;36:114-7.
35. De Caprio C, Alfano A, Senatore I, et al. Severe acute liver damage in anorexia nervosa: Two case reports. Nutrition 2006;22:572-5.
36. Sakada M, Tanaka A, Ohta D, et al. Severe steatosis resulted from anorexia nervosa leading to fatal hepatic failure. J Gastroenterol 2006;41:714-5.
37. Ozawa Y, Shimizu T, Shishiba Y. Elevation of serum aminotransferase as a sign of multiorgan-disorders in severely emaciated anorexia nervosa. Intern Med 1998;37:32-9.
38. Quigley E, Marsh M, Shaffer J, et al. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993;104:286-301.
39. Paquot N, Delwaide J. Fatty liver in the intensive care unit. Curr Opin Clin Nutr Metab Care 2005;8:183-7.
40. Montagnese C, Scalfi L, Signorini A, et al. Cholinesterase and other serum liver enzymes in underweight outpatients with eating disorders. Int J Eat Disord 2007;40:746-50.
41. Nova E, Lopez-Vidriero I, Varela P, et al. Evolution of serum biochemical indicators in anorexia nervosa patients: A 1-year follow-up study. J Hum Nutr Diet 2008;21:23-30.
42. McClain CJ, Humphries LL, Hill KK, et al. Gastrointestinal and nutritional aspects of eating disorders. J Am Coll Nutr 1993;12:466-74.
43. Morris LG, Stephenson KE, Herring S, et al. Recurrent acute pancreatitis in anorexia and bulimia. JOP 2004;5:231-4.
44. Pieper-Bigelow C, Strocchi A, Levitt MD. Where does serum amylase come from and where does it go? Gastroenterol Clin North Am 1990;19:793-810.
45. Hütter G, Ganepola S, Hofmann WK. The hematology of anorexia nervosa. Int J Eat Disord 2009;42:293-300.
46. Mant MJ, Faragher BS. The haematology of anorexia nervosa. Br J Haematol 1972;23:737-49.
47. do Carmo I, Palma-Carlos ML, Melo A, et al. Characterization of leukocytes, lymphocytes and lymphocyte subsets in eating disorders. Allerg Immunol 1997;29:261-8.
48. Stabler SP, Allen RH. Vitamin B12 deficiency as a worldwide problem. Annu Rev Nutr 2004;24:299-326.
49. Killip S, Bennett JM, Chambers MD. Iron deficiency anemia. Am Fam Physician 2007;75:671-8.
50. Boullu-Ciocca S, Darmon P, Sébahoun G, et al. Gelatinous bone marrow transformation in anorexia nervosa. Ann Endocrinol 2005;66:7-11.
51. Kay J, Stricker RB. Hematologic and immunologic abnormalities in anorexia nervosa. South Med J 1983;76:1008-10.
52. Hurd HP, Palumbo PJ, Gharib H. Hypothalamic-endocrine dysfunction in anorexia nervosa. Mayo Clin Proc 1977;52:711-6.
53. Bowers TK, Eckert E. Leucopenia in anorexia nervosa: Lack of increased risk of infection. Arch Int Med 1978;138:1520-3.
54. Veselinovic T, Himmerich H. Antihistaminergic antipsychotics cause weight gain. Nervenarzt 2009, Nov. 11 [epub ahead of print].
55. Bissada H, Tasca GA, Barber AM, et al. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: A randomized, double-blind, placebo-controlled trial. Am J Psychiatry 2008;165:1281-8.
56. Monteleone P, Castaldo E, Maj M. Neuroendocrine dysregulation of food intake in eating disorders. Regul Pept 2008;149:39-50.
57. Ehrlich S, Burghardt R, Schneider N, et al. The role of leptin and cortisol in hyperactivity in patients with acute and weight-recovered anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:658-62.
58. Holtkamp K, Herpertz-Dahlmann B, Hebebrand K, et al. Physical activity and restlessness correlate with leptin levels in patients with adolescent anorexia nervosa. Biol Psychiatry 2006;60:311-3.
59. Holtkamp K, Herpertz-Dahlmann B, Mika C, et al. Elevated physical activity and low leptin levels co-occur in patients with anorexia nervosa. J Clin Endocrinol Metab 2003;88:5169-74.
60. Muñoz MT, Argente J. Anorexia nervosa in female adolescents: Endocrine and bone mineral density disturbances. Eur J Endocrinol 2002;147:275-86.
61. Baranowska B, Wolinska-Witort E, Wasilewska-Dziubinska E, et al. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa. Neuro Endocrinol Lett 2001;22:356-8.
62. Fujimoto S, Inui A, Kiyota N, et al. Increased cholecystokinin and pancreatic polypeptide responses to a fat rich meal in patients with restrictive but not bulimic anorexia nervosa. Biol Psychiatry 1997;41:1068-70.
63. Nakai Y, Hamagaki S, Takagi R, et al. Plasma concentrations of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in patients with anorexia nervosa. J Clin Endocrinol Metab 1999;84:1226-8.
64. Inui A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key? Cancer Res 1999;59:4493-501.
65. Himmerich H, Fulda S, Linseisen J, et al. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur Cytokine Netw 2006;17:196-201.
66. Himmerich H, Fulda S, Linseisen J, et al. Depression, comorbidities and the TNF-alpha system. Eur Psychiatry 2008;23:421-9.
67. Inui A. Eating behavior in anorexia nervosa: An excess of both orexigenic and anorexigenic signalling? Mol Psychiatry 2001;6:620-4.
68. Jayasinghe Y, Grover SR, Zacharin M. Current concepts in bone and reproductive health in adolescents with anorexia nervosa. BJOG 2008;115:304-15.
69. Furuta M, Funabashi T, Kimura F. Intracerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats. Biochem Biophys Res Commun 2003;288:780-5.
70. De Souza MJ, Leidy HJ, O'Donnell E, et al. Fasting gherelin levels in physically active women: Relationship with menstrual disturbances and metabolic hormones. J Clin Endocrinol Metab 2004;89:3536-42.
71. Terasawa EI, Fernandez DL. Neurobiological mechanism of the onset of puberty in primates. Endocr Rev 2001;22:111-51.
72. Kopp W, Blum WF, von Prittwitz S, et al. Low leptin levels predict amenorrhea in underweight and eating disordered females. Mol Psychiatry 1997;2:335-40.
73. Brambilla F, Monteleone P. Physical complications and physiological aberrations in eating disorders: A review. In: Maj M, Halmi K, Lopez-Ibor JJ, et al. eds. Eating disorders. Chichester: Wiley & Sons; 2003: 139-92.
74. Schenry CC, Clifton DK, Steiner RA. Proopiomelanocortin neurons and direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-92.
75. Gold PW, Loriaux DL, Roy A, et al. Abnormal hypothalamic pituitary-adrenal function in anorexia nervosa. Pathophysiology mechanisms in underweight and weight-corrected patients. N Engl J Med 1986;314:1339-42.
76. Fichter MM, Doerr P, Pirke KM, et al. Behavior, attitude, nutrition and endocrinology in anorexia nervosa. Acta Psychiatr Scand 1982;66:429-44.
77. Shibasaki T, Imaki T, Hotta M, et al. Psychological stress increases arousal through brain corticotropin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion. Brain Res 1993;618:71-5.
78. Kiyohara K, Tamai H, Takaichi Y, et al. Decreased thyroidal triiodothyronine secretion in patients with anorexia nervosa: Influence of weight recovery. Am J Clin Nutr 1989;50:767-72.
79. Muñoz MT, Argente J. Anorexia nerviosa y bulimia nerviosa. In: Argente J, Carrascosa C, Gracia R, et al. eds. Tratado de Endocrinologia Pediatrica y de la Adolescencia. Barcelona: Doyma; 2000: 1333-51.
80. Leslie RD, Isaacs AJ, Gomez J, et al. Hypothalamo-pituitary-thyroid function in anorexia nervosa: Influence of weight gain. Br Med J 1978;2:526-8.
81. Hübner G, Voss C, Hartmann N. Physiology and pathophysiology of ketone bodies. I. Formation of ketone bodies, their metabolic role and determination methods in blood and urine. Z Gesamte Inn Med 1974;29:45-51.
82. Misra M, Klibanski A. Neuroendocrine consequences of anorexia nervosa in adolescents. Endocr Dev 2010;17:197-214.
83. Winston AP, Alwazeer AE, Bankart MJ. Screening for osteoporosis in anorexia nervosa: Prevalence and predictors of reduced bone mineral density. Int J Eat Disord 2008;41:284-7.
84. Kanbur N, Mesci L, Derman O, et al. Tumor necrosis factor alpha-308 gene polymorphism in patients with anorexia nervosa. Turk J Pediatr 2008;50:219-22.
85. Corcos M, Guilbaud O, Chaouat G, et al. Cytokines and anorexia nervosa. Psychosom Med 2001;63:502-4.